Clin2
NCT06740838Possibly a fitRecruiting

Overnight dexamethasone test for aldosterone screening

Primary AldosteronismHypertension

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial is testing a new way to screen for a hormone problem called primary aldosteronism (which can cause high blood pressure) by giving a steroid pill (dexamethasone) overnight. You may be eligible if you have high blood pressure and an adrenal growth, and are already scheduled for a related hormone test.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
240 people
Ages
40 years to 75 years
Study type
Observational

Who can take part

  • You are between 40 and 75 years old.
  • You have high blood pressure (hypertension) or it's suspected.
  • You have a growth on your adrenal gland that looks like a harmless adenoma or hyperplasia.
  • Your doctor has already scheduled a test called the 1-mg dexamethasone suppression test (a pill you take to check for mild cortisol problems).
  • You are not taking steroids, anti-inflammatory drugs, hormone therapy, birth control pills, or licorice supplements.
  • You do not have severe kidney disease, poorly controlled diabetes, severe obesity, active cancer, or other serious health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06941116Recruiting
Steroid test to screen for a common cause of high blood pressure

This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.

Chongqing, Chongqing Municipality
NCT06571084Recruiting
New screening for primary aldosteronism in hypertension

This trial looks for better ways to diagnose primary aldosteronism (PA), a common cause of high blood pressure that can be treated. It may help find people whose hypertension is caused by this condition so they can get the right treatment sooner.

Beijing
NCT06616142Recruiting· Phase 1/Phase 2
New imaging test for primary aldosteronism

This trial tests a new imaging method called [18F]CETO PET scan to better understand the cause of high blood pressure due to primary aldosteronism (PA). It may help guide treatment decisions without needing more invasive tests.

Groningen, Provincie Groningen
NCT07635134Recruiting
Testing a new method to diagnose primary aldosteronism

This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.

Beijing, Beijing Municipality
NCT07646535Not yet recruiting· Phase 2
SAL0140 study for primary aldosteronism and high blood pressure

This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.

Shanghai, Shanghai Municipality
NCT07621458Recruiting
Primary Aldosteronism Blood Test Measurement Study

This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.

Seoul, Korea, Republic of

Hear when a new Primary Aldosteronism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.